Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals Announces Multiple Presentations At American Association of Cancer Research Annual Meeting
April 16, 2009 07:00 ET | Cyclacel
BERKELEY HEIGHTS, N.J., April 16, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today the presentation of preclinical data from its two most advanced...
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals Announces Suspension of Quarterly Dividend On 6% Convertible Exchangeable Preferred Stock
April 08, 2009 07:00 ET | Cyclacel
BERKELEY HEIGHTS, N.J., April 8, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (the "Company") announced that its Board of Directors passed a resolution to...
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals Announces Financial Results for Fourth Quarter and Year Ended December 31, 2008
March 31, 2009 16:01 ET | Cyclacel
BERKELEY HEIGHTS, N.J., March 31, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today financial results and milestone highlights for the fourth quarter...
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals to Announce Fourth Quarter 2008 Financial Results On March 31, 2009
March 24, 2009 07:00 ET | Cyclacel
BERKELEY HEIGHTS, N.J., March 24, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) will announce fourth quarter 2008 financial results on Tuesday, March 31, 2009....
Cyclacel Pharmaceuticals logo
Cyclacel Announces Phase 1 Data Published Elucidating Pharmacodynamics & Mechanism of Action of Seliciclib in Nasopharyngeal Cancer
March 05, 2009 07:00 ET | Cyclacel
BERKELEY HEIGHTS, N.J., March 5, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced publication of an investigator-sponsored Phase 1 study reporting...
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals Advances Oral Sapacitabine Pivotal Trial Plan in Hematological Malignancies
February 06, 2009 07:00 ET | Cyclacel
BERKELEY HEIGHTS, N.J., Feb. 6, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC), (Nasdaq:CYCCP) announced today progress with a pivotal trial plan for sapacitabine, its oral...
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals to Present At BIO CEO & Investor Conference
February 02, 2009 07:00 ET | Cyclacel
BERKELEY HEIGHTS, N.J., Feb. 2, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today that its President and Chief Executive Officer, Spiro Rombotis,...
Cyclacel Pharmaceuticals logo
Cyclacel Begins Phase 2 Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer
January 13, 2009 07:00 ET | Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 13, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today that the company has begun treating patients in a Phase 2, open...
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals to Present At Two Upcoming Investor Conferences
November 13, 2008 13:34 ET | Cyclacel
BERKELEY HEIGHTS, N.J., Nov. 13, 2008 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today that its President and Chief Executive Officer, Spiro Rombotis,...
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals to Present At Rodman & Renshaw 10th Annual Healthcare Conference
November 07, 2008 10:49 ET | Cyclacel
BERKELEY HEIGHTS, N.J., Nov. 7, 2008 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC), (Nasdaq:CYCCP) announced today that its President and Chief Executive Officer, Spiro Rombotis,...